In a previous study, our group concluded that the detection of COL1A2 and KRT19 mRNA in the extracellular vesicles (EVs) of patients with advanced malignant solid tumors could be a valid and reliable neoplastic detection method [16]. The gene discussed is COL1A2; the disease is cancer.